Early third instar larvae expressing cacRQ,SL.UAS.EGFP under the control of Scer\GAL4elav-C155 develop protruding, anterior spiracles prematurely, which normally only develop at wandering third instar stage and pupation.
In CNS-removed larvae, NMJ neurotransmission shows significant increases in mEPSP frequency, amplitude and rise time, and a significant increase in EPSP amplitude, but not quantal content, as compared to controls; there are rare gigantic spontaneous events, which are never observed in controls. Upon 30 presynaptic pulses, EPSP profiles show extra discharges but no shoulders; if expression is induced only 24h or 48h prior to third instar larval stage (by Gal80[ts] and temperature shift to 29[o]C) there is progressive spontaneous hyper-excitability.
In intact CNS larvae, NMJ neurotransmission show a high degree of spontaneous activity compared to controls, marked by rapid, continuous large pulses.
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by Plc21CGD11359, Scer\GAL4elav-C155
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by Galphaq[+]/Gαq28
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by Gαq221c/Galphaq[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by Df(2L)BSC4/+
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by Plc21C[+]/Plc21CA
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by Plc21CMI01911/Plc21C[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, enhanceable | female limited by RyR16/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-enhanceable by RyRE4340K/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-enhanceable by RyR[+]/RyRR4305C
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-enhanceable by RyR[+]/RyRk04913
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-enhanceable by RyRQ3878X/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-enhanceable by RyRY4452X/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has abnormal neurophysiology | larval stage phenotype, suppressible by Plc21CGD11359, Scer\GAL4elav-C155
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has abnormal neurophysiology | larval stage phenotype, suppressible | partially by Itprug3/Itp-r83A[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has abnormal neurophysiology | larval stage phenotype, suppressible | partially by RyRE4340K/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-suppressible by RyRE4340K/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-suppressible by RyR[+]/RyRR4305C
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-suppressible by RyR[+]/RyRk04913
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-suppressible by RyRQ3878X/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has partially lethal - majority die phenotype, non-suppressible by RyRY4452X/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has embryonic/larval neuromuscular junction | larval stage phenotype, suppressible | partially by RyRE4340K/RyR[+]
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has embryonic/larval neuromuscular junction | larval stage phenotype, suppressible by Plc21CGD11359, Scer\GAL4elav-C155
Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP has embryonic/larval neuromuscular junction | larval stage phenotype, suppressible | partially by Itprug3/Itp-r83A[+]
Female larvae expressing cacRQ,SL.UAS.EGFP under the control of Scer\GAL4elav-C155 exhibit a significant increase in NMJ mEPSP amplitude and frequency; the increased amplitude is suppressed by Plc21CGD11359 co-expression or RyRE4340K heterozygosity, and partially suppressed by Itp-r83Aug3 heterozygosity; the gigantic spontaneous events are also diminished (Itp-r83Aug3/+) or abrogated (RyRE4340K/+). The NMJ hyperexcitability (i.e. EPSP extra discharges) in cacRQ,SL.UAS.EGFP-expressing larvae is also suppressed by RyRE4340K heterozygosity.
Scer\GAL4elav-C155/cacRQ,SL.UAS.EGFP fails to rescue cacHC129